Accelerating global access to life-saving vaccines.

We apply rigorous science to build knowledge and support for the value of vaccines.

Updates

Webinar: Achieving the Sustainable Development Goals – Reaching the Communities Left Furthest Behind

September 2022

Register for webinar: https://bit.ly/oct-2022-webinar When: October 7th, 2022 at 8:30am-9:30am ET Description: The COVID-19 pandemic has affected countries and people in very different ways, making the SDG’s principle to Leave No One Behind particularly relevant as decision makers at all levels consider recovery plans to build back better from the lingering pandemic. Reaching zero-dose children […]

VIRA Partners to Launch a Competition and Chatbot

August 2022

VIRA is a COVID-19 vaccine chatbot created by the Johns Hopkins International Vaccine Access Center and IBM to provide users with instant answers on vaccine questions 24/7. VIRA, which works in English and Spanish, understands users’ questions in natural language, and responds with facts and empathy. The VIRA project is excited to announce that it […]

New estimates reveal alarming stagnation in global access to pneumococcal conjugate vaccines

July 2022

Vaccines for pneumonia are critical tools for helping to reduce the number of childhood deaths around the world. The pneumococcal conjugate vaccine (PCV) is a lifesaving vaccine that protects children against pneumonia, the number one infectious killer amongst children under 5. According to the recently released WUENIC data, just 51% of infants in the world […]